Add Trial
Sign In

MERU / M16-298 - Hosted By


A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer

Study Type Interventional (Clinical Trial)
Sponsor Name Abbvie
Disease type Small Cell Lung Cancer
Disease Stage IV
Clinical Status Maintenance Therapy
Phase III
Intervention / Treatment Rovalpituzumab Teserine
Research Site IUCPQ
Investigator Dre Lise Tremblay
Coordinator Brigitte Fortn
Telephone number
Fax number
Study start date 26-Jan-17
Study end date
Trial Status Recruiting


Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialit, n'incluez pas le nom du patient

Hosted by :

More from this author :

Claim listing: MERU / M16-298

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message


Account details will be confirmed via email.

Reset Your Password